Insmed (INSM) net assets (shareholders' equity)

Net assets · fiscal 2025
$738.98M

Insmed (INSM) had net assets of $738.98M at the end of fiscal 2025 (December 31, 2025). That is 158.9% higher than the $285.38M of fiscal 2024. Figures as of 19 Nov 2026, 03:14 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Net assets, fiscal 2025
$738.98M
Change on fiscal 2024
+158.9%
Growth, 5 years
+21.8% a year
Growth, 10 years
+9.0% a year
Highest on record
$738.98Mfiscal 2025
Lowest on record
-$331.92Mfiscal 2023
Fiscal years on record
172009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Insmed net assets (shareholders' equity), in more detail

Over the five fiscal years to 2025 net assets grew at a compound 21.8% a year; over ten years the rate was 9.0% a year. Across the 17 fiscal years on record (2009–2025), the highest was $738.98M in fiscal 2025 and the lowest -$331.92M in fiscal 2023.

History · 17 fiscal years

Net assets by fiscal year

Insmed net assets (shareholders' equity), year by year

Insmed (INSM) net assets (shareholders' equity) by fiscal year
Fiscal yearNet assetsChangeYear ended
2025$738.98M 158.9% up
2024$285.38M—
2023-$331.92M 477.4% down
2022$87.95M 78.6% down
2021$410.47M 48.8% up
2020$275.88M 5.4% up
2019$261.67M 25.6% up
2018$208.27M 42.3% down
2017$361.06M 133.7% up
2016$154.48M 50.4% down
2015$311.70M 67.4% up
2014$186.24M 29.9% up
2013$143.32M 18.6% up
2012$120.88M 10.0% down
2011$134.27M 30.4% down
2010$192.84M 55.6% up
2009$123.91M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value.

How to read it

Large buybacks and write-offs shrink it without the business getting worse, so a falling or negative figure needs the reason before a verdict.

Net assets at health care companies of similar size

Net assets of Insmed and comparable companies
CompanyNet assetsFiscal year
STERIS STE$7.18B2026
Insmed INSM$738.98M2025
United Therapeutics UTHR$7.10B2025
Incyte INCY$5.17B2025
Viatris VTRS$14.71B2025
Tenet Healthcare THC$4.22B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on INSM

Insmed, figure by figure

Insmed (INSM) overview: price, valuation and scorecardAll health care companies by market value

Insmed net assets (shareholders' equity): questions and answers

What are Insmed's net assets?

Insmed (INSM) had net assets of $738.98M at the end of fiscal 2025 (December 31, 2025). That is 158.9% higher than the $285.38M of fiscal 2024.

What is the growth rate of Insmed's net assets?

Over the five fiscal years to 2025 net assets grew at a compound 21.8% a year; over ten years the rate was 9.0% a year.

What are the highest and lowest net assets figures on record for Insmed?

Across the 17 fiscal years on record (2009–2025), the highest was $738.98M in fiscal 2025 and the lowest -$331.92M in fiscal 2023.

How is Insmed's net assets calculated?

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value. For Insmed it is on record here for 17 fiscal years, 2009 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Insmed (INSM) net assets (shareholders' equity)”, data as of 19 November 2026. https://funkfolio.com/stock/INSM/net-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.